T3	Subject 22 41	a 40 year old woman
T4	Treat-Disorder 81 103	leptomeningeal disease
T5	Treatment 55 76	intraventricular IL-2
T6	Effect 118 151	progressive cognitive dysfunction
T8	Age 24 35	40 year old
T9	Gender 36 41	woman
T10	Drug 72 76	IL-2
T7	Adverse_event 108 117	developed
E1	Adverse_event:T7 
T1	Route 55 71	intraventricular
